Teva Recalls Cephalexin Oral Suspension Due to Low Potency
Teva Pharmaceuticals is recalling Cephalexin for Oral Suspension because test results showed the drug was below the required potency specification.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard is a sub-potent drug (low potency) without reported injuries or illnesses, which aligns with the Moderate severity criteria for low-risk contamination or voluntary precautionary recalls.
Plain-English summary
Teva Pharmaceuticals USA is recalling 38,487 bottles of Cephalexin for Oral Suspension, USP 250 mg per 5 mL. The product is identified by Lot # 30310638A and has an expiration date of 02/2022. The recall was initiated because out-of-specification test results indicated that the drug's potency was below the required specification.
The affected product is a prescription-only oral suspension distributed nationwide in the U.S. and Puerto Rico. The specific NDC for the recalled item is 0093-4177-73.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or healthcare provider for guidance on replacement or further instructions.
The recalled product
- Product
- CEPHALEXIN (CEPHALEXIN)
- Brand
- CEPHALEXIN
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Antibiotic
- Hazard
- Affected units
- 38,487
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 30310638A
- Exp. 02/2022
UPCs (2)
- 0300934175738
- 0300934177732
Distribution
Part of a larger recall action
This product is one of 3 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · CEPHALEXIN
- ModerateCephalexin Oral Suspension Recalled for Failed Impurity Specifications
FDA (Drugs) · 2025-06-18
- ModerateCephalexin Oral Suspension Recalled for Failed Impurities Specifications
FDA (Drugs) · 2025-06-18
- ModerateCephalexin oral suspension recalled for incorrect dose labeling
FDA (Drugs) · 2024-06-12
- LowCephalexin for Oral Suspension Recalled for Back Label Error
FDA (Drugs) · 2024-06-12
- ModerateCephalexin Oral Suspension Recalled for Incorrect Dosage Label
FDA (Drugs) · 2024-06-12
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · sub potent drug
See all →- HighLorazepam Tablets Recalled Due to Sub-Potency and Failed Stability Testing
FDA (Drugs) · 2025-02-26
- ModerateKillz Germz Hand Sanitizer Recalled for Sub-Potent Ethanol Levels
FDA (Drugs) · 2020-10-28
- ModerateKillz Germz Hand Sanitizer Recalled for Sub-Potent Alcohol Levels
FDA (Drugs) · 2020-10-28
- ModeratePacira Recalls Sub-Potent Exparel Bupivacaine Injectable Vials
FDA (Drugs) · 2019-12-11